Stefan Schreiber Selected Research

Stefan Schreiber Research Topics

Disease

99	Crohn Disease (Crohn's Disease) 11/2022 - 05/2002
62	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022 - 04/2002
57	Ulcerative Colitis 01/2022 - 03/2004
40	Inflammation (Inflammations) 01/2022 - 03/2004
27	Neoplasms (Cancer) 01/2022 - 09/2006
26	Infections 11/2022 - 09/2003
17	Necrosis 01/2021 - 06/2004
14	Obesity 01/2022 - 05/2007
14	Insulin Resistance 10/2021 - 01/2006
14	Colitis 12/2017 - 09/2008
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2005
9	Rheumatoid Arthritis 01/2022 - 02/2005
8	Periodontitis 05/2022 - 11/2008
8	Sarcoidosis (Schaumann Disease) 04/2021 - 04/2005
8	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015 - 08/2007
7	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 06/2007
7	Atherosclerosis 01/2022 - 06/2007
7	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 01/2011
7	Cholelithiasis 06/2013 - 09/2006
7	Asthma (Bronchial Asthma) 04/2011 - 05/2003
6	Ankylosing Spondylitis 04/2022 - 06/2017
6	Hemorrhage 01/2022 - 07/2002
6	Body Weight (Weight, Body) 01/2022 - 11/2005
6	Carcinogenesis 01/2022 - 12/2005
6	Disease Progression 01/2016 - 03/2005
5	COVID-19 05/2022 - 10/2020
5	Heart Failure 12/2021 - 09/2007
5	Chronic Disease (Chronic Diseases) 01/2021 - 10/2004
5	Gallstones (Gallstone) 06/2013 - 11/2006
5	Sepsis (Septicemia) 03/2013 - 07/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2007
4	Weight Loss (Weight Reduction) 12/2021 - 06/2015
4	Atopic Dermatitis (Atopic Eczema) 01/2020 - 02/2008
4	Ulcer 01/2020 - 01/2012
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018 - 08/2011
4	Sclerosing Cholangitis 01/2018 - 08/2010
4	Fibrosis (Cirrhosis) 01/2018 - 01/2011
4	Aggressive Periodontitis (Periodontosis) 10/2017 - 11/2008
4	Myocardial Infarction 12/2013 - 05/2007
4	Tuberculosis (Tuberculoses) 05/2012 - 02/2010
4	Genetic Predisposition to Disease (Genetic Predisposition) 06/2010 - 01/2005
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2010 - 03/2006
3	Proctitis 11/2022 - 01/2021
3	Wounds and Injuries (Trauma) 11/2022 - 05/2002
3	Rheumatic Diseases (Rheumatism) 05/2022 - 11/2019
3	Psoriatic Arthritis 04/2022 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2005

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
25	Infliximab (Remicade)FDA Link 05/2022 - 10/2002
22	Pharmaceutical PreparationsIBA 11/2022 - 08/2007
19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2002
17	Certolizumab Pegol FDA Link 01/2021 - 09/2005
15	CytokinesIBA 05/2022 - 04/2003
15	Biological ProductsIBA 11/2021 - 10/2004
13	Monoclonal AntibodiesIBA 01/2022 - 06/2004
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2007
12	vedolizumabIBA 01/2022 - 01/2014
12	Adalimumab (Humira)FDA Link 01/2022 - 01/2007
12	Messenger RNA (mRNA)IBA 12/2017 - 09/2006
10	C-Reactive ProteinIBA 01/2022 - 03/2006
9	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 08/2005
9	Insulin (Novolin)FDA Link 10/2021 - 01/2006
9	Biosimilar PharmaceuticalsIBA 10/2021 - 01/2015
9	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2012
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2004
8	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2002
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2007
7	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 03/2004
6	AntibodiesIBA 01/2022 - 03/2009
6	LipidsIBA 01/2022 - 07/2012
6	MicroRNAs (MicroRNA)IBA 11/2016 - 09/2010
6	Transcription Factors (Transcription Factor)IBA 01/2014 - 01/2009
5	IntegrinsIBA 07/2022 - 08/2013
5	Azathioprine (Imuran)FDA LinkGeneric 07/2022 - 06/2004
5	InterleukinsIBA 07/2022 - 06/2009
5	etrolizumabIBA 01/2022 - 08/2013
5	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 12/2009
5	EnzymesIBA 10/2020 - 11/2006
5	Mesalamine (Mesalazine)FDA LinkGeneric 09/2020 - 01/2007
5	Ribosomal DNA (rDNA)IBA 01/2018 - 12/2007
5	Dextrans (Dextran)FDA Link 01/2014 - 06/2009
5	Leucine (L-Leucine)FDA Link 12/2012 - 01/2005
5	NF-kappa B (NF-kB)IBA 02/2010 - 09/2007
4	CholesterolIBA 01/2022 - 11/2006
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 07/2020
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 06/2011
4	CT-P13IBA 01/2021 - 09/2016
4	Small Interfering RNA (siRNA)IBA 05/2017 - 02/2010
4	Interleukin-23 (Interleukin 23)IBA 01/2017 - 02/2009
4	DefensinsIBA 01/2015 - 01/2008
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2014 - 06/2009
4	Acetylmuramyl-Alanyl-IsoglutamineIBA 01/2012 - 12/2007
3	tofacitinibIBA 01/2022 - 01/2017
3	risankizumabIBA 01/2022 - 01/2017
3	LDL CholesterolIBA 01/2022 - 08/2008

Therapy/Procedure

66	Therapeutics 11/2022 - 07/2004
10	Biological Therapy 01/2022 - 09/2007
4	Aftercare (After-Treatment) 01/2020 - 10/2002
4	Liver Transplantation 01/2018 - 06/2013
4	Cholecystectomy 03/2013 - 09/2006